Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV
1 clinical trials · Condition
◉ Watch Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV
| Record | Firm | Date |
|---|---|---|
| Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer (NCT01809210) | AstraZeneca | 2013-04-04 |
Track Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV automatically
Every clearance here is in the API, with alerts when new ones post.